Evidence for a continuous decline in haemopoietic cell function from birth: application to evaluating bone marrow failure in children
- 1 July 1999
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 106 (1), 162-166
- https://doi.org/10.1046/j.1365-2141.1999.01477.x
Abstract
There are considerable differences in haemopoietic activity between young children and adults on the one hand, and between adults and the elderly on the other. A fundamental unanswered question is whether these differences relate to discrete stages or are part of a continuous process. We have sought to define aspects of the haematological ageing process, and have found that results from children with bone marrow failure syndromes differ from age-matched reference values. Haemopoietic cells were obtained from umbilical cord blood, from blood and bone marrow of healthy individuals and from the blood of young patients with bone marrow failure syndromes. Clonogenic myeloid progenitors (CFU-GM) were grown in semi-solid medium to measure their frequency; the proliferative capacity of myeloid progenitors was measured by replating colonies and observing secondary colony formation. We found that the frequency of CFU-GM in normal marrow increased and their proliferative capacity decreased exponentially with age. The proliferative capacity of CFU-GM in normal blood also decreased exponentially with age. This relationship extrapolated back to the levels of proliferation measured for cord blood CFU-GM (age = 0). The proliferative capacities of CFU-GM from children with bone marrow failure syndromes were severely reduced compared with age-matched reference values. These results indicate that a decline in haemopoietic progenitor cell function begins at birth and continues throughout life. This decline may occur prematurely in childhood marrow failure syndromes with a predisposition to leukaemia.Keywords
This publication has 20 references indexed in Scilit:
- Treatment with interferon-alpha preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors (CFU-GM) from patients with chronic myeloid leukemia but spares normal CFU-GM.Journal of Clinical Investigation, 1998
- Reconstruction of the Hematopoietic System After Stem Cell TransplantationCell Transplantation, 1998
- X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functionsNature Genetics, 1998
- Molecular Biology of Fanconi Anemia: Implications for Diagnosis and TherapyBlood, 1997
- Acquired skewing of X‐chromosome inactivation patterns in myeloid cells of the elderly suggests stochastic clonal loss with ageBritish Journal of Haematology, 1997
- The aging of hematopoietic stem cellsNature Medicine, 1996
- The effect of age on hemopoiesisAging Clinical and Experimental Research, 1996
- Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age.Proceedings of the National Academy of Sciences, 1994
- Low Doses of Cytarabine in the Treatment of Myelodysplastic Syndrome and Acute Myeloid LeukemiaNew England Journal of Medicine, 1983
- The anemia of senescenceAmerican Journal of Hematology, 1981